Long‐term safety and efficacy of antimuscarinic add‐on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study)
2018 ◽
Vol 26
(3)
◽
pp. 342-352
◽
Keyword(s):
2017 ◽
Vol 198
(4)
◽
pp. 928-936
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. TPS325-TPS325
◽
Keyword(s):
2019 ◽
Vol 43
(1)
◽
pp. 51-52
2012 ◽
Vol 11
(1)
◽
pp. e683-e683a
◽